BLOOD CENTER OF SOUTHEASTERN W has a total of 18 patent applications. Its first patent ever was published in 1984. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are GEADIC BIOTEC AIE, EXPRESSIVE CONSTRUCTS INC and COMPUGEN USA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 3 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Measuring microorganism processes | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Newman Peter J | 14 |
#2 | Aster Richard H | 11 |
#3 | Curtis Brian R | 3 |
#4 | Gumina Richard J | 1 |
#5 | Kirshbaum Nancy | 1 |
#6 | Montgomery Robert R | 1 |
#7 | Kunicki Thomas J | 1 |
Publication | Filing date | Title |
---|---|---|
US6087331A | Therapeutic use of platelet-endothelial cell adhesion molecule-1 compositions | |
US5585243A | Method of detecting cytopenia that is mediated by drug-dependent antibody binding to blood cells | |
WO9301315A1 | PEN POLYMORPHISM OF HUMAN PLATELET MEMBRANE GLYCOPROTEIN IIIa AND DIAGNOSTIC AND THERAPEUTIC APPLICATION THEREOF | |
US5264554A | Platelet cell adhesion molecule and variants thereof | |
US5436163A | Polymorphism of human platelet membrane glycoprotein IIb and diagnostic applications thereof | |
US5091302A | Polymorphism of human platelet membrane glycoprotein iiia and diagnostic and therapeutic applications thereof | |
US4710381A | Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing |